(Q40945240)

25 September 2017

title

Intracellular single-chain antibody against hepatitis B virus core protein inhibits the replication of hepatitis B virus in cultured cells (English)

1 reference

25 September 2017

1 reference

Yamamoto M

1

1 reference

25 September 2017

Hayashi N

2

1 reference

25 September 2017

Takehara T

3

1 reference

25 September 2017

Ueda K

4

1 reference

25 September 2017

Mita E

5

1 reference

25 September 2017

Tatsumi T

6

1 reference

25 September 2017

Sasaki Y

7

1 reference

25 September 2017

Kasahara A

8

1 reference

25 September 2017

Hori M

9

1 reference

25 September 2017

language of work or name

English

0 references

publication date

1 July 1999

1 reference

25 September 2017

1 reference

25 September 2017

volume

30

1 reference

25 September 2017

issue

1

1 reference

25 September 2017

page(s)

300-307

1 reference

Clinical aspects of hepatitis B virus infection

25 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300105

7 January 2021

Risk factors for hepatocellular carcinoma among patients with chronic liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300105

7 January 2021

Effect of Alpha-Interferon Treatment in Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis B

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300105

7 January 2021

A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. The Hepatitis Interventional Therapy Group

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300105

7 January 2021

The treatment effect of alpha interferon in chronic hepatitis B is independent of pre-treatment variables. Results based on individual patient data from 10 clinical controlled trials. European Concerted Action on Viral Hepatitis (Eurohep).

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300105

7 January 2021

Lamivudine therapy for chronic hepatitis B: a six-month randomized dose-ranging study

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300105

7 January 2021

Lamivudine is effective in suppressing hepatitis B virus DNA in Chinese hepatitis B surface antigen carriers: a placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300105

7 January 2021

Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300105

7 January 2021

Inhibition of hepatitis B virus by antisense oligodeoxynucleotides

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300105

7 January 2021

In vivo inhibition of duck hepatitis B virus replication and gene expression by phosphorothioate modified antisense oligodeoxynucleotides.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300105

7 January 2021

Viral genetic variation: hepatitis B virus as a clinical example

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300105

7 January 2021

Gene therapy for chronic viral hepatitis: ribozymes, antisense oligonucleotides, and dominant negative mutants

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300105

7 January 2021

https://api.crossref.org/works/10.1002%2FHEP.510300105

1 reference

7 January 2021

Phage antibodies: filamentous phage displaying antibody variable domains

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300105

7 January 2021

Single-chain antigen-binding proteins

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300105

7 January 2021

Stable expression and replication of hepatitis B virus genome in an integrated state in a human hepatoma cell line transfected with the cloned viral DNA

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300105

7 January 2021

An in vitro system for screening anti-hepatitis B virus drugs

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300105

7 January 2021

Basic local alignment search tool

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300105

7 January 2021

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300105

7 January 2021

Replication of the genome of a hepatitis B-like virus by reverse transcription of an RNA intermediate

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300105

7 January 2021

Tumor necrosis factor-alpha and interferon-gamma inhibit synergistically viral replication in hepatitis B virus-replicating cells

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300105

7 January 2021

Interferon inhibits hepatitis B virus replication in a stable expression system of transfected viral DNA.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300105

7 January 2021

Construction and initial characterization of a mouse-human chimeric anti-TNF antibody

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300105

7 January 2021

Identifiers

DOI

10.1002/HEP.510300105

1 reference

25 September 2017

1 reference